Companies/US/GANX

GAIN THERAPEUTICS, INC.

Last · NASDAQ$1.32-0.00000005245 (-0.00%)live · yahoo · 2h ago
Vol 369.2K ≈ 487.3K
Market cap$57.61M43.6M sh
P/E · TTM-2.8fwd -1.9 · eps -0.47 · loss
Beta0.19vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.295$4.34
Volume369.2Ksession

Issuer

Legal nameGAIN THERAPEUTICS, INC.
HQUnited States (US)
ListingUS GANX
ISINUS36269B1052
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001819411
CIK0001819411
Websitegaintherapeutics.com
LinkedIn
Employees21
AddressGain Therapeutics, Inc. 4800 Montgomery Lane 20814, Bethesda
Loading chart…

Press & signals

2 recent
  • GlobeNewswire

    Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update

  • GlobeNewswire

    Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

Documents

FormReporting forFiledFlags
8-KCurrent Report (8-K)
—2026-10-010
8-KCurrent Report (8-K)
—2026-09-280
10-Q
2026-06-302026-08-11 3
8-K8-K: Other Events
2026-06-292026-06-290
8-K8-K: Submission of Matters to a Vote of Security Holders
2026-06-242026-06-250
Showing 5 of 20 filings